| AHI (0-5) | AHI (5-15) | AHI (15-30) | AHI (30-) | P |
---|---|---|---|---|---|
Subjects | 50 | 67 | 89 | 205 | Â |
Age, years | 44.36 ± 16.18 | 49.70 ± 11.64 | 49.72 ± 12.98 | 49.45 ± 13.62 | 0.105 |
Male sex, number (%) | 30 (60Â %) | 41 (61.19Â %)***** | 69(77.52Â %) | 172(83.9Â %)***, ***** | 0.000 |
Current smoking, number (%) | 6(12Â %) | 12(17.91Â %) | 19(21.35Â %) | 44(21.46Â %) | 0.445 |
Antilipimic agents, number (%) | 2(4Â %) | 3(4.48Â %) | 4(4.49Â %) | 14(6.83Â %) | 0.772 |
Antidiabetic agents, number (%) | 1(2Â %) | 4(5.97Â %) | 6(6.74Â %) | 16(7.80Â %) | 0.522 |
Antihypertensive agents, number (%) | 8(16Â %) | 12(17.91Â %) | 27(30.34Â %) | 56(27.32Â %) | 0.108 |
Waist circumference (cm) | 88.70 ± 10.35**, *** | 90.43 ± 8.79****, ***** | 94.58 ± 8.43**, ****, ****** | 98.26 ± 10.27***, *****, ****** | 0.000 |
BMI (kg/m)2 | 23.94 ± 3.03**, *** | 24.98 ± 3.25***** | 25.94 ± 3.69**, ****** | 27.84 ± 5.93***, *****, ****** | 0.000 |
AHI | 2.14(0.80-4.25)*, **, *** | 9.30(7.20-12.30)*, ****, ***** | 21.30(18.25-24.25)**, ****, ****** | 52.40(40.95-65.45)***, *****, ****** | 0.000 |
Mean SpO2 (%) | 96.50 (95.00-97.00)**, *** | 96.00(95.00-96.00)***** | 95.00(94.00-96.00)**, ****** | 92.00(88.00-94.00)***, *****, ****** | 0.000 |
LaSO2 (%) | 90.00(84.75-92.00)**, *** | 86.00(80.00-88.00)****, ***** | 79.00(75.00-85.50)**, ****, ****** | 67.00(57.00-78.00)***, *****, ****** | 0.000 |
TS90% (%) | 0.00(0.00-0.36)**, *** | 0.18(0.02-0.78)***** | 0.98(0.10-2.57)**, ****** | 7.60(2.71-17.93)***, *****, ****** | 0.000 |
ODI | 1.50(0.50-3.40)**, *** | 6.30(3.40-9.40)****, ***** | 15.54(9.58-19.95)**, ****, ****** | 46.20(31.60-62.40)***, *****, ****** | 0.000 |